Peak Bio- Warrants (05/01/2026)'s operating income is $-950.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2025
Trailing 12 months ending Jun 30, 2025
As of the most recent data (June 2025), PKBOW shows a operating income of $-950. That compares with $-3.4M in the prior-year period — up 100.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PKBOW's operating income is now $-950 (was $-3.4M) — a 100.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Peak Bio- Warrants (05/01/2026) is outperforming or lagging.
Tracking PKBOW's operating income over time shows whether Peak Bio- Warrants (05/01/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $-950 That compares with $-3.4M in the prior-year period — up 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this operating income page, Stockcircle has Peak Bio- Warrants (05/01/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-950) with ownership activity and broader fundamentals.